RYTM Rhythm Pharmaceuticals, Inc. logo

RYTM Rhythm Pharmaceuticals, Inc.

Healthcare
$88.47+0.00%OpenMarket Cap: $6.06B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

7

Dispositions

7

Buy/Sell Ratio

1.00

Net Shares

+12,422

Shares Acquired

37,382

Shares Disposed

24,960

Total Bought ($)

$0.00

Total Sold ($)

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Smith Hunter Cofficer: Chief Financial OfficerSell3,000$17.87119,611
Tue May 19German Christopher Paulofficer: Corporate Controller & CAOSell4,643$92.210
Tue May 19German Christopher Paulofficer: Corporate Controller & CAOSell1,687$56.693,713
Tue May 19German Christopher Paulofficer: Corporate Controller & CAOSell1,406$17.974,643
Tue May 19German Christopher Paulofficer: Corporate Controller & CAOSell1,349$49.233,237
Fri Apr 03Popovits Kimberly JdirectorSell10,257$88.1210,257
Fri Apr 03Popovits Kimberly JdirectorSell6,808$0.006,808
Fri Apr 03Popovits Kimberly Jdirector: Sell0$0.000
Fri Apr 03Mazabraud Yannofficer: EVP, Head of InternationalSell12,875$0.0066,030
Fri Apr 03Mazabraud Yannofficer: EVP, Head of InternationalSell10,375$0.0010,375
Fri Apr 03Mazabraud Yannofficer: EVP, Head of InternationalSell2,500$0.005,000
Mon Mar 16Mathers Edward TdirectorSell4,199$0.0014,168
Fri Mar 06German Christopher Paulofficer: Corporate Controller & CAOSell5,614$89.56160
Fri Mar 06German Christopher Paulofficer: Corporate Controller & CAOSell1,500$17.975,753
Wed Mar 04Mazabraud Yannofficer: EVP, Head of InternationalSell35,000$94.9435,000